Adderall - 0555-0766-02 - (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate)

Alphabetical Index


Drug Information of Adderall

Product NDC: 0555-0766
Proprietary Name: Adderall
Non Proprietary Name: Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Active Ingredient(s): 3.75; 3.75; 3.75; 3.75    mg/1; mg/1; mg/1; mg/1 & nbsp;   Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Adderall

Product NDC: 0555-0766
Labeler Name: Barr Laboratories Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA040422
Marketing Category: ANDA
Start Marketing Date: 20080811

Package Information of Adderall

Package NDC: 0555-0766-02
Package Description: 100 TABLET in 1 BOTTLE (0555-0766-02)

NDC Information of Adderall

NDC Code 0555-0766-02
Proprietary Name Adderall
Package Description 100 TABLET in 1 BOTTLE (0555-0766-02)
Product NDC 0555-0766
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20080811
Marketing Category Name ANDA
Labeler Name Barr Laboratories Inc.
Substance Name AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Strength Number 3.75; 3.75; 3.75; 3.75
Strength Unit mg/1; mg/1; mg/1; mg/1
Pharmaceutical Classes Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]

Complete Information of Adderall


General Information